Podcast appearances and mentions of megan thomas

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Our news highlights this time focus on two major regulatory agencies, in a week that saw the European Commission (EC) launch a new fund designed to tempt US researchers to EU countries, and the US Food and Drugs Administration (FDA) roll out extensive new AI systems. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Our highlights this week demonstrate a variety of approaches to cancer treatment, including a BTK inhibitor, macrophage checkpoint inhibitor, and antibody-drug conjugates, at various stages of development. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the American Association of Cancer Research (AACR) Annual Meeting taking place from 25-30 April, the DDW news desk has been inundated with the latest advances in cancer drug discovery, so here are a few highlights. Check out our round-up for the event for more updates. You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Dimitrios Goundis, CEO of Kither Biotech. Kither is a Phase I, soon to be Phase II, Italian biotech focused on respiratory diseases such as cystic fibrosis. This episode explores how emerging biotech strategies are advancing treatments for respiratory diseases like cystic fibrosis, with a focus on targeted drug delivery, clinical trial progression, and the evolving biotech landscape in Europe. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With Eli Lilly so far winning the race to bring an oral GLP-1 drug to market, having announced positive topline results from a Phase III trial, this week our news highlights focus on clinical studies. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. In a week of financial uncertainty for the industry, our round-up focuses on the power of partnership to accelerate drug discovery, from the prevention of respiratory infections, to mapping gene activity in inflammatory bowel disease. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

This is the latest episode of the free DDW narrated podcast, titled “Innovation enabled by new drug discovery technologies”, which covers three articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Sitting down with… Neil Dhawan”, “Meet the researcher: Giusy Di Conza, iOnctura” and “From the Top: Adele Hannigan, Antibody Analytics”. In the first article, Reece Armstrong speaks to Neil Dhawan, the Co-founder and CEO of Totus Medicines about the company's approach to drug discovery using fundamental technologies in chemistry, biology and artificial intelligence (AI). In the second article, Megan Thomas looked at a day in the life of Giusy Di Conza, Head of Research at iOnctura. In the third article, Megan Thomas shines a spotlight on Adele Hannigan, CBO for Antibody Analytics, which has since been rebranded as RoukenBio.

This is the latest episode of the free DDW narrated podcast, titled “Innovation enabled by new drug discovery technologies”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Finding the North Star of therapeutic antibodies” and “Which diseases will benefit from therapeutic antibody development?” In the first article, Katie Abouzahr is the Vice President, Autoantibody Portfolio and Maternal Fetal Disease Area Leader at the Janssen Pharmaceutical Companies of Johnson & Johnson. She speaks with Megan Thomas about the future for Janssen's investigational medicine nipocalimab and antibody therapeutics at large. In the second article, DDW's Megan Thomas looks at how different diseases will benefit from the success of therapeutic antibodies.

Jake and Megan Thomas join Pastor Jenaye in today's episode to share their journey through infertility, foster care, and adoption. They discuss how they learned to surrender their plans to God's timing and encourage believers to step into uncomfortable, vulnerable spaces while trusting His plan. The couple also shares how The Lily Initiative has been instrumental in supporting them through the challenges of foster care.thelilyinitiative.orgnexusfamilyhealing.org

The latest episode of the DDW Highlights podcast is now available to listen. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Weight loss drugs have been making the news this week. As we come to the end of Women's History Month, two of the covered studies focus on women's health, specifically the role of weight loss drugs in treating endometriosis and why women have worse side effects from these therapeutics.  You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week the DDW news round-up takes a look at developments in cancer research, including AZ's acquisition of EsoBiotec, positive trial results for an allogeneic T-cell therapy, and a new drug target for glioblastoma. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Clinical trials of all stages have dominated the DDW news section this week. All the stories represent a significant step forward for drug discovery, either due to the innovative nature of the therapies being studied, or the unique methods employed in the trial. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Our news round-up this week focuses on start-ups, the innovative fledgling companies that are coming through and sparking new life into various areas of drug discovery. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. It's been a mixed bag of news for gene therapies this week, ranging from huge successes in treating sight impairment, cystic fibrosis and hearing loss, to the quick sale of a previously successful gene therapy developer. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

It's party time! The Football v Homophobia campaign is in the mood for dancing because Awards Night is here once again - and this year, we're all going to Glasgow!This is the sixth staging of the only event of its kind, recognising outstanding achievement in the field of LGBTQ+-inclusive football - from the professional clubs setting the standard, to the fan groups that are bringing folks back to the game, to the FvH Heroes going above and beyond… their moment of acclaim is here, and we just can't wait to celebrate.To preview the Awards in this special episode, we're joined by two guests who know the Scottish game inside out, and not least the city's LGBTQ+ football scene - it's Amanda Aitken and Megan Thomas from The Sideline podcast.Since it started in May 2024, Amanda and Megan's pod has quickly become a must-listen, mixing big interviews with the likes of Tessel Middag and Elaine C. Smith, alongside truly nourishing natters with grassroots champions like Glasgow Pride Community Football, Cathkin Blazes, Glasgow Saints, to name but a few.If you're hitting play before Awards Night on Friday 7 March, consider this your essential preview (and if you haven't yet bought a ticket, hurry! Link below)... if you're late to this episode, fear not, as there's still loads to enjoy, as The Sideline duo spill the beans on podcasting, their own club Camp Hellcats FC, their dream guests, and much more.Links..The Sideline Podcast - https://podfollow.com/1749278705 The Sideline on Instagram - https://www.instagram.com/_thesidelinepodcast/ Buy FvH Awards Night tickets! - https://www.eventbrite.co.uk/e/football-v-homophobia-awards-night-2025-tickets-1216203149359 FvH Awards 2025 shortlists - https://www.footballvhomophobia.com/football-v-homophobia-awards-2025-shortlists-announced/ Sports Media LGBT+ - https://sportsmedialgbt.com/ Thank you for listening to the FvH Podcast - please subscribe, rate, review and share on socials.We're at @FvHtweets on Twitter / X; @football_v_homophobia on Instagram; and you can find us on Bluesky, Facebook and Threads too. Our website is https://www.footballvhomophobia.com/ Me & You by MusicbyAden | https://soundcloud.com/musicbyaden  Music promoted by https://www.free-stock-music.com  Creative Commons Attribution-ShareAlike 3.0 Unportedhttps://creativecommons.org/licenses/by-sa/3.0/deed.en_US 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Following the news of cuts to medical research funding from the National Institutes of Health (NIH), this week we focus on some positive drug discovery news from North America, including FDA priority review for a number of innovative therapeutics and a new US centre for rare disease research. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Love is in their air this Valentine's Day as this week's news round-up celebrates the importance of collaboration in life sciences, whether that's in the sharing of data, technology, or expertise. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Following World Cancer Day on 4 February, the news round-up this week focuses on new approaches to the treatment of cancer, including radiopharmaceuticals, programmable cell depletion and preventative vaccines. You can listen here, or find The Drug Discovery World Podcast on Spotify or Google Play.

Recent data shows that just 8% of us have actually received professional financial advice, while the number of financial advisors willing to work with smaller portfolios is falling. With that in mind, Money expert Megan Thomas and Chris Justham, Managing Director of Intermediary Solutions at financial advisors 7iM demystify the world of financial advice and explore whether or not AI could help bring the industry to the masses. Read more about financial advice & sign up to our free weekly Money newsletter. Become a Which? Money member and receive a special gift - offer ends 16 February 2025. Get 50% off a Which? membership.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. In the same week that Phesi revealed that breast cancer is the most studied disease for the fourth year in a row, we have seen a number of breakthroughs in the treatment of solid tumours, both in the early preclinical and later clinical stages of research.  You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week we have seen a number of positive announcements related to the early clinical and preclinical development of immunotherapies, including an islet cell therapy for diabetes, an antibody-drug conjugate and a CAR-T therapy for multiple myeloma, and a peptide-drug conjugate and a vaccine for head and neck cancers. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Our news round-up at the end of last year focused on drug discovery investment, so it is positive to see that this has also started strong in 2025, with a number of new acquisitions, research partnership agreements and financings to kick off the new year. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. As we approach the end of 2024, it's great to see that investment in drug discovery is still going strong, with an impressive $300 million raised by AI-focused company SandboxAQ and another significant financing by Ottimo Pharma. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. It's been a big week for cell and gene therapies (CGTs) as the first in vivo BCMA CAR-T candidate reaches the clinic and a new discovery could lead to a gene therapy that reverses a significant cause of stillbirth and premature delivery. You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week's leading news stories all shine a light on innovation within drug discovery, including a potential ‘best-in-industry' weight loss drug, a gold-based compound that shrinks tumours by 82%, and a second-generation CAR-T therapy. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week's leading news stories all feature early-stage clinical trials, including a short interfering RNA for cardiovascular disease, a new type of drug for type 2 diabetes, a gene therapy for Duchenne muscular dystrophy, a T cell therapy for hepatitis B, and a monoclonal antibody to prevent respiratory syncytial virus. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week's most exciting news stories all represent innovative solutions to the treatment of disease, proving that ‘thinking outside the box' can by the key to success in drug discovery. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the Society for Immunotherapy of Cancer (SITC) 2024 taking place in Houston recently, there have been a number of recent announcements regarding the clinical advancement of immunocytokines, METTL3 inhibitors, cancer vaccines, CAR-T therapies and immune checkpoint inhibitors for the treatment of cancer. You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week DDW has reported on significant investment in the development of treatments for neurodegenerative diseases, but also gene therapies for CNS disorders and radioligand-based therapies for cancer. You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

Megan Thomas grew up heavily involved in her Baptist world, steeped in Scripture, prayer, mission trips, and more. However, she still felt like something was missing in the way she understood Christianity. As she grew older and she began to take greater ownership of her faith, Megan realized that a lot of the arguments she was using to defend her faith had their greatest roots in the Catholic intellectual tradition. That revolutionized her Christian worldview, and helped her complete the incomplete picture of Christianity she'd been struggling with for years.

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. In a week that saw a second monoclonal antibody rejected by UK regulator NICE, antibodies have been high on the news agenda. More positively, a new indication for Fasenra was approved in the EU, researchers found an antibody platform could overcome the challenges of treating mutating viruses, and monoclonal antibodies showed promise in lung cancer and immunoglobulin A nephropathy. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with CEO of Oxeia, Dr Michael  Wyand, where we talk about Oxeia's work; the unmet critical need for concussion drug therapies; the challenges facing them, including in clinical trials and investment; the potential market for concussion drugs, and more. You can now, and find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With a presidential election just round the corner in the US and a new UK budget on the way, financial support for life sciences is high on the agenda, so the news round-up this week focuses on investment in drug discovery, by private investors, governments and charities. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. As we are halfway through Breast Cancer Awareness Month, our news highlights this week focus on studies that could advance the treatment of cancer in the future, including a new understanding of cancer drug resistance, and novel therapeutics like radioimmunotherapy, RBM39 degraders and peptide-drug conjugates. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Recently, the Society for Neuroscience's annual meeting took place, so the headlines have been dominated by the latest discoveries related to the brain and the central nervous system, including significant findings related to GLP-1 agonists and an advanced theory of bipolar disorder. If these are of interest, don't forget to register for DDW's Neuroscience Showcase on 24 October. You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week we have seen a number of developments related to cell therapies, particularly CAR-T cell therapies, beyond their traditional use in haematological malignancies. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week, DDW has opened registrations for its webinar ‘The latest advancements driving neuroscience drug discovery research', so our news highlights focus on developments in neuroscience, including a novel drug that has been shown to reduce neuronal death, and a potential disease-modifying treatment for dementia. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Dr Friso Postma, Vice President of AI Drug Discovery at BioXcel Therapeutics. Thanks to BioXcel's AI platform, the company was able to repurpose previous drugs to obtain FDA approval for its acute treatment for agitation associated with schizophrenia and bipolar disorder, IGALMI, in April 2022, which was the first drug development success that involved the actual use of AI. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the release of clinical study results that led some media titles to ask if semaglutide could be a ‘fountain of youth', this week our news highlights focus on clinical trials at a variety of different stages. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the launch of an international clinical trial investigating BioNTech's mRNA lung cancer vaccine announced this week, our news highlights focus on clinical trials, including studies of a monoclonal antibody and small molecule GLP-1 agonist for obesity, and a muscarinic M4 selective agonist for schizophrenia. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. It's been a busy week for medical regulatory agencies, with a number of key decisions made on therapies for graft-versus-host-disease, neuroendocrine carcinoma, haemophilia B, lymphoma and non-small cell lung cancer. You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The chosen news highlights this week all feature advances in drug development in oncology indications and reflect the breadth of therapeutic approaches to cancer treatment. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The news highlights this week all centre around significant US Food and Drug Administration (FDA) regulatory decisions, including new approvals for drugs for solid tumours, hepatitis B and glioma. You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. GLP-1 receptor agonists have dominated the headlines this week, with data revealed on new potential beneficial effects of treatment with semaglutide and dual receptor agonists like pemvidutide. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW's Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. There have been some interesting developments in neuroscience this week. Perhaps most note-worthy, shingles vaccines Shingrix has been shown to reduce the risk of dementia by 17%, and TikoMed's ALS drug caused a long-term slowing of ALS progression in a Phase II trial. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts. 

This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers five articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: The promise and growth of cell and gene therapies No sign of stopping: The rise of cell and gene therapy Expert view: What's next for cell and gene therapy? Understanding the future roadmaps of cell and gene therapy Under the microscope: Zoning in on the CGT sector In the first article, DDW's Megan Thomas comments on the state of the CGT industry. In the second, Ryan Leahy, a science communication expert in cell and gene therapy, at Phacilitate, says there is a lot to celebrate but also much to assess, question and challenge in this sector. In the third, DDW's Megan Thomas explores the global innovations in cell and gene therapy and what opportunities and challenges are emerging and can therapies get to market faster. In the fourth, DDW's Megan Thomas caught up with George White, General Manager, Product Management, Cell & Gene Therapy at Cytiva, to learn more about the company's insight into the CGT market. In the fifth and final article, IB Communications' CEO Michelle Boxall explains why there are two sides to the cell and gene therapy coin.

“The strength of our culture was something we used in the presentations to analysts and investors”, says Daniel. “We did some work around our employee value proposition and we asked our colleagues, ‘Why do you work at Hamilton?' The common theme was collaboration and that's how we came up with the phrase ‘In good company'. As part of the IPO, we used it as our overall company tagline to say, ‘You're in good company with Hamilton, whether you're a client, broker, stakeholder or investor.'”On the Insurance Coffee House Podcast, Daniel shares his career journey from the NatWest graduate programme, his varied roles at Munich Re to joining Hamilton Insurance Group six years ago. He talks about the transition from a larger, more corporate environment to starting his current role at Hamilton, with 120 people and $500m in premium in 2018. “Joining Hamilton, I was excited for the opportunity to be at a company, almost at its start and helping it build. It's very different to being at a large organisation. What excites people about joining Hamilton is that you feel you can move the needle.”The business has subsequently grown to 550+ employees, with $2bn in premium and listed on the NYSE in November 2023. Daniel gives an overview of the core functions of the business today and his role of overseeing the HR function, internal and external communications, as well as developing the strength of culture Hamilton has become known for. “We firmly believe that having a strong culture is critical and a component of our overall underwriting success. Engaged employees are an essential part of Hamilton's success. They drive productivity and innovation, that will lead to the ultimate success of the company.”Daniel explains how Hamilton's values of ‘Be smart, Be sensible, Be open, Be more' underpin activity around recruitment, performance management and talent management, as well as the key role communication plays. Regular town halls at both group and local level, together with ‘Hamilton on a page' lays out strategy and helps employees understand current performance and achieve our business imperatives of sustainable underwriting profit, strategic growth, technology enablement and being a magnet for talent.Daniel highlights the importance of collaboration and how the outcomes of staff surveys help address any team concerns. He shares his advice for leaders coming to interview at Hamilton and advises his insurance industry HR peers not to rush the hiring process if they're unsure of a candidate, but to move with haste if they are. Daniel explains Hamilton's DEI statement, ‘Open minds open doors' and how welcoming and respecting differences, helps attract and retain the best talent. “We embrace all forms of diversity, ethnicity, sexual orientation, religion, but gender has been something we're particularly proud of what we've been able to achieve.Of our total employee base, 45% are female. 36% of our Underwriting leads and Claims leads are female. There's always room for growth, but we're extremely proud of that progress we've been able to make in that area.”Daniel stresses the key leadership roles and influence of Pina Albo, Anita Kuchma, Megan Thomas and Gemma Carreiro at executive level. “Pina is the first female CEO of a Bermuda-based company to ring the New York Stock Exchange bell and Hamilton was the first woman-led insurance company to go public in 20 years.” Daniel emphasizes what he looks for an in an insurance executive search partner, including trust and third-party perspectives and insights. He concludes by adding the one lesson his career has taught him, he thinks everyone should know. “There are always other forms of information that come through to you as a professional, but having good, solid data to help you make decisions is such an important...

In this week's episode of Catholic ReCon, testimonies from reverts and converts, Megan Thomas of  @FiledUnderFaith  gets right to the point, asking us all to think about where we're looking for answers. Do we want to find the truth of Christ and His Church? If so, we should not fear exploring without bias. #Catholic #Protestant #Testimony #Conversion #Light #Faith #ChristianStories #Love #Charity #JourneyHome #CatholicChurch #JesusChrist #Clarity If you'd like to share your personal testimony, please fill out the form here: https://bit.ly/3bdE6pr Wherever you are on the journey, God bless you. For more information, visit eddietrask.com. --- Support this podcast: https://podcasters.spotify.com/pod/show/eddie-trask/support

Marketing experts Megan Thomas, Content & Social Marketing Manager at ResMan, and Mateo Quintero, Manager of Website Design at Razz, talk shop about websites, specifically for properties. With a flood of new units coming on the market, resulting in oversupply and fierce competition around occupancy, Mateo shares what makes a property's website stand out from the rest. They talk branding, UI/UX, visual appeal, and interactive features on a website that make the difference in conversion rates.Mateo Quintero is the Manager of Website Design at Razz, the brand within Inhabit that powers ResMan Websites. With over a decade of multifamily industry experience, he leads UX/UI design initiatives for the Razz CMS platform and website templates, emphasizing smart design strategies that drive conversions and engagement.  Mateo joined Razz as a graphic designer in 2016 after several years in creative roles within a digital marketing agency. He holds a BA in Graphic Design and a minor in Marketing from UCF.Connect with Mateo on LinkedIn: https://www.linkedin.com/in/mqteo/About Razz: Razz is an award-winning digital agency providing a modern perspective on marketing with well-designed and easily customizable websites and branding for properties in the multifamily and vacation industries. Razz is part of Inhabit, a global PropTech software company serving the residential and vacation property management industries. With Inhabit, we are All Together. All Driven. All In. Learn more about Razz here: https://www.myrazz.com/If you're a ResMan customer, you can also learn about ResMan Websites powered by Razz: https://www.myresman.com/solutions/websitesAbout ResMan: ResMan delivers the property management industry's most innovative technology platform, making property investments and operations more profitable and easier to manage. ResMan's platform unlocks a new path to growth for property management companies that deliver consistent NOI improvement and brilliant resident experiences easier than ever before. To learn more about our platform, visit http://myresman.com/